Back to search

France· FR:65540866

VESANOID 10 mg, capsule molle

A medicinal product containing trétinoïne, registered in France by CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE).

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVESANOID 10 mg, capsule molleATC—REGISTER NO.FR:65540866PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TRÉTINOÏNE
Manufacturer
CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400936586970
    flacon(s) en verre brun de 100 capsule(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Trétinoïne in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trétinoïne products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Vesanoid
  • Belgium · Vesanoid
  • Germany · Cordes Vas, Vesanoid
  • Spain · Neocare, Retirides
  • Finland · Avitcid, Vesanoid
  • United Kingdom (Northern Ireland) · Tretinoin Neon Healthcare, Vesanoid
  • Croatia · Vesanoid
  • Ireland · Vesanoid
  • Italy · Tretinoina Same Savoma Medicinali, Vesanoid
  • Malta · Ketrel
  • Netherlands · Vesanoid
  • Poland · Vesanoid
  • Portugal · Ketrel, Vesanoid
  • Slovakia · Vesanoid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5b1011e-0978-4ad2-a9ef-5bbb554299fd
GET /v1/drugs/f5b1011e-0978-4ad2-a9ef-5bbb554299fd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65540866",
  "date_amm": "1996-01-16",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "TRÉTINOÏNE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "capsule molle",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about trétinoïne.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.